2007
DOI: 10.1002/ajmg.a.31921
|View full text |Cite
|
Sign up to set email alerts
|

Familial CHARGE syndrome and the CHD7 gene: A recurrent missense mutation, intrafamilial recurrence and variability

Abstract: CHARGE syndrome is an autosomal dominant condition that is caused by mutations in the CHD7 gene. Few familial cases of this syndrome have been reported and these were characterized by a wide clinical variability. We here report on five CHD7 mutation positive families and comment on their clinical features. We observed somatic and germline mosaicism as well as parent-to-child transmission of non-mosaic CHD7 mutations as causes of familial CHARGE syndrome. In one family with two affected sibs a somatic mutation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
99
0
3

Year Published

2010
2010
2020
2020

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 85 publications
(105 citation statements)
references
References 24 publications
1
99
0
3
Order By: Relevance
“…The discovery of loss‐of‐function mutations in the CHD7 gene in patients with CHARGE syndrome (Janssen et al, 2012; Vissers et al, 2004), has led to significant progress in elucidating the developmental and molecular genetic mechanisms underlying specific phenotypes associated with CHARGE syndrome (Layman, Hurd, & Martin, 2010). However, CHARGE syndrome is characterized by significant variability in incidence and severity of specific abnormalities, which does not correlate with the nature of CHD7 mutation (Basson & van Ravenswaaij‐Arts, 2015; Bergman, Janssen et al, 2011; Jongmans et al, 2008). These observations implicate other genetic or non‐genetic factors, or even stochastic effects as modifiers of disease severity.…”
Section: Introductionmentioning
confidence: 99%
“…The discovery of loss‐of‐function mutations in the CHD7 gene in patients with CHARGE syndrome (Janssen et al, 2012; Vissers et al, 2004), has led to significant progress in elucidating the developmental and molecular genetic mechanisms underlying specific phenotypes associated with CHARGE syndrome (Layman, Hurd, & Martin, 2010). However, CHARGE syndrome is characterized by significant variability in incidence and severity of specific abnormalities, which does not correlate with the nature of CHD7 mutation (Basson & van Ravenswaaij‐Arts, 2015; Bergman, Janssen et al, 2011; Jongmans et al, 2008). These observations implicate other genetic or non‐genetic factors, or even stochastic effects as modifiers of disease severity.…”
Section: Introductionmentioning
confidence: 99%
“…15 In Patient 3, CHD7 sequencing revealed an intronic variant predicted to disrupt the exon 6 donor splice site (c.2442+5G4C; NM_017780.3; g.127819G4C; NG_007009.1). The same variant was present in his affected older brother 9 and their mildly affected father. The variant was not present in the ExAC database.…”
Section: Methodsmentioning
confidence: 62%
“…Missense variants in CHD7 are relatively uncommon in the literature, and it is possible that mild or atypical CHARGE phenotypes, such as we report, have been under-recognized. Variable expressivity is common in autosomal dominant transmission of CHD7 variants, 9 and it is uncertain whether the p.(Thr1133Met) variant predisposes to a mild phenotype or could lead to typical CHARGE syndrome in some individuals.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations